Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the
Continue Reading The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I
Bigfoot Biomedical® Secures up to $57 Million in Financing from Madryn Asset Management
Bigfoot Biomedical®, a Milpitas, CA emerging company, recently announced that it has secured new financing of up to $57
Continue Reading Bigfoot Biomedical® Secures up to $57 Million in Financing from Madryn Asset Management
Dana-Farber Launches New Fund to Support Oncology Startups
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups
Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
On January 11, 2020, the Broad Institute, Verily Life Sciences, and Microsoft announced a strategic partnership to accelerate biomedical innovations
Continue Reading Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion
Continue Reading As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal
World Economic Forum Releases Top 10 Emerging Technologies of 2020
Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10
Continue Reading World Economic Forum Releases Top 10 Emerging Technologies of 2020